Your browser doesn't support javascript.
loading
Immune response to COVID-19 vaccination is attenuated by poor disease control and antimyeloma therapy with vaccine driven divergent T-cell response.
Ramasamy, Karthik; Sadler, Ross; Jeans, Sally; Weeden, Paul; Varghese, Sherin; Turner, Alison; Larham, Jemma; Gray, Nathanael; Carty, Oluremi; Barrett, Joe; Bowcock, Stella; Oppermann, Udo; Cook, Gordon; Kyriakou, Chara; Drayson, Mark; Basu, Supratik; Moore, Sally; McDonald, Sarah; Gooding, Sarah; Javaid, Muhammad K.
Afiliación
  • Ramasamy K; Oxford University Hospitals NHS Trust, Radcliffe Department of Medicine, Oxford University, Oxford, UK.
  • Sadler R; Department of Immunology, Churchill Hospital, Oxford University Hospitals NHS, Foundation Trust, Oxford, UK.
  • Jeans S; The Botnar Research Centre, Headington, UK.
  • Weeden P; The Botnar Research Centre, Headington, UK.
  • Varghese S; Late Phase Haematology, Oxford University Hospital NHS Foundation Trust, Churchill Hospital, Oxford, UK.
  • Turner A; Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK.
  • Larham J; Oxford University Hospitals NHS Trust, Oxford, UK.
  • Gray N; Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK.
  • Carty O; Department of Immunology, Churchill Hospital, Oxford University Hospitals NHS, Foundation Trust, Oxford, UK.
  • Barrett J; Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK.
  • Bowcock S; Princess Royal University Hospital, King's College Hospital Foundation NHS Trust, Kent, UK.
  • Oppermann U; Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK.
  • Cook G; NIHR Leeds Medtech & In vitro Diagnostics Cooperative, Leeds Teaching Hospitals Trust, Leeds, UK.
  • Kyriakou C; Department of Haematology, University College London Hospitals NHS Trust, London, UK.
  • Drayson M; College of Medical and Dental Sciences Medical School, University of Birmingham, Birmingham, UK.
  • Basu S; University of Wolverhampton, The Royal Wolverhampton NHS Trust, Wolverhampton, UK.
  • Moore S; Oxford University Hospitals NHS Trust, NHS Foundation Trust, Oxford and Bath Royal United Hospitals, Bath, UK.
  • McDonald S; Myeloma UK, Beaverbank Business Park, Edinburgh, UK.
  • Gooding S; MRC Molecular Haematology Unit, Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.
  • Javaid MK; Department of Haematology, Oxford University Hospitals NHS Trust, Oxford, UK.
Br J Haematol ; 197(3): 293-301, 2022 05.
Article en En | MEDLINE | ID: mdl-35064676
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 1_ASSA2030 / 2_ODS3 / 4_TD Problema de salud: 1_doencas_nao_transmissiveis / 2_enfermedades_transmissibles / 2_muertes_prematuras_enfermedades_notrasmisibles / 4_pneumonia Asunto principal: COVID-19 / Mieloma Múltiple Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Adult / Humans / Male Idioma: En Revista: Br J Haematol Año: 2022 Tipo del documento: Article País de afiliación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 1_ASSA2030 / 2_ODS3 / 4_TD Problema de salud: 1_doencas_nao_transmissiveis / 2_enfermedades_transmissibles / 2_muertes_prematuras_enfermedades_notrasmisibles / 4_pneumonia Asunto principal: COVID-19 / Mieloma Múltiple Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Adult / Humans / Male Idioma: En Revista: Br J Haematol Año: 2022 Tipo del documento: Article País de afiliación: Reino Unido